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http:WHAT THIS PAPER ADDS
Currently, few clinically relevant risk factors for abdominal aortic aneurysm (AAA) rupture have been validated
other than aneurysm diameter. Vascular calciﬁcation already has an established role in cardiovascular risk
analysis. We measured increased calciﬁcation in patients with symptomatic and ruptured AAA as opposed to
electively repaired AAA. This study shows the potential of vascular calciﬁcation as a novel additional tool for risk
assessment and provides an argument to intensify research on this subject.Objectives: Abdominal aortic aneurysm (AAA) is a major cause of death in developed countries. The AAA
diameter is still the only validated prognostic measure for rupture, and therapeutic interventions are initiated
accordingly. This still leads to unnecessary interventions in some cases or unidentiﬁed impending ruptures.
Vascular calciﬁcation has been validated abundantly as a risk factor in the cardiovascular ﬁeld and may
strengthen the rupture risk assessment of the AAA. With this study we aim to assess the correlation between
AAA calciﬁcation and rupture risk in a retrospective unmatched case-control population.
Methods: A database of 334 AAA patients was evaluated. Three groups were formed: elective (eAAA; n ¼ 233),
ruptured (rAAA; n ¼ 73) and symptomatic non-ruptured (sAAA; n ¼ 28) AAA patients. The Abdominal Aortic
Calciﬁcation-8 score (AAC-8) was used to measure the severity of vascular calciﬁcation.
Results: The AAA diameter (61  12 mm vs. 74  21 mm; p < .001) and AAC-8 score (3.4  2 points vs. 4.9  2.3
points; p < .001) of the eAAA and the combined rAAA and sAAA groups, respectively, were signiﬁcantly different
after univariate analysis. Multivariate analysis showed that larger AAA diameter (odds ratio [OR]: 1.048/mm
increase; 95% conﬁdence interval [CI]: 1.042e1.082; p < .001) and a higher AAC-8 score (OR: 1.34/point
increase; 95% CI: 1.19e1.53; p < .001) were signiﬁcantly associated with development into a sAAA or rAAA.
Peripheral artery disease was signiﬁcantly correlated to eventual elective treatment (OR: 0.39; 95% CI: .15e1;
p ¼ .049).
Conclusion: This study suggests a trend of an increased degree of calciﬁcation in symptomatic or even ruptured
AAA patients compared with elective AAA patients.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysm (AAA) is a major cause of death
in Western countries with more 8,000 reported deaths in
the UK annually. Acute rupture may lead to death in up to
90% of patients and 40e70% of these patients who receive
surgery will not survive. Also, the 30-day postoperative
mortality has been reported as being 6% after elective
surgery versus 37% after emergency surgery.1,2 In itsresponding author. C.J. Zeebregts, Department of Surgery, Division
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//dx.doi.org/10.1016/j.ejvs.2013.09.006current state, risk stratiﬁcation of AAA is solely based on the
maximum diameter of the abdominal aorta. However, the
importance of the aortic diameter has come under debate
in recent literature.3,4 Though diameter is predictive of
rupture in large population studies like the United Kingdom
Small Aneurysm Trial5 and the Aneurysm Detection and
Management trial,6 it reﬂects poorly on individual risk
assessment. It has become questionable whether a large
aneurysm diameter alone is sufﬁcient to justify interven-
tion. On the other side of the spectrum, the rupture risk
analysis of small aneurysms (3.5e5.0 cm) is being recon-
sidered as this particular patient group could suffer from
preventable rupture. However, the risks of re-intervention,
complications including death, and of unnecessary inter-
vention remain a clear threat for both endovascular and
open surgical repair. To enhance the potential of current
Table 1. Patient characteristics, measured data, and common risk
factors. Elective abdominal aortic aneurysm (AAA) patients were
compared to non-elective AAA patients (mean  SD).
Variable Elective AAA
(n ¼ 230)
Non-elective
AAA
(n ¼ 91)
p
Age (y) 70  7.7 72  8.2 .25
Serum creatinine (mg/dL) 101  56 109  39 .17
Blood pressure (mmHg) e e e
Systolic 137  22 138  25 .8
Diastolic 78  12 77  14 .71
Mean arterial pressure 98  14 98  17 .94
Body mass index 27  4 27  4 .82
AAC-8 (points) 3.4  2.3 4.9  2.2 <.001
AAA diameter (mm) 62  12 77  20 <.001
Diabetes mellitus (%) 16 21 .31
Hypertension (%) 61 64 .63
Cardiovascular disease (%) 73 64 .1
Peripheral artery
disease (%)
21 8 .004
AAA in family history (%) 3 4 .54
Other aneurysms (%) 9 6 .28
Deceased (%) 10 13 .48
Smoking e e e
Never (%) 32 46 .013
Stopped (%) 26 18 .11
Current (%) 42 36 .30
Treatment e e e
Endovascular (%) 56 29 <.001
Open (%) 44 63 .003
No surgery (%) 0 9 <.001
Male gender (%) 93 92 .96
Chronic obstructive
pulmonary disorder (%)
27 24 .67
Note. AAC-8 ¼ Abdominal Aortic Calciﬁcation-8 score.
Table 2. Distribution of four potential combinations of calciﬁcation
grade and diameter size.
Variable Elective AAA
(n ¼ 230)
Non-elective
AAA (n ¼ 91)
p
AAC-8 score >4 and
high-risk diameter (%)
29 55 <.001
AAC-8 score >4 and
low-risk diameter (%)
3 6 .2
AAC-8 score 4 and
high-risk diameter (%)
63 40 <.001
AAC-8 score 4 and
low-risk diameter (%)
6 0 .021
Note. High-risk diameter: >50 mm for women and >55 mm for
men. AAA ¼ abdominal aortic aneurysm; AAC-8 ¼ Abdominal
Aortic Calciﬁcation-8 score.
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should be added. Additional risk factors have already been
identiﬁed and tested intensively, although just a few remain
promising for clinical validation.4 The prognostic value of
calciﬁcation has been described extensively in cardiovas-
cular risk assessment.7 Calciﬁcation has been shown to be a
sign of a degenerative inﬂammatory process involved in the
arterial wall.8e11 For that reason, we hypothesize that the
risk of rupture is associated with the degree of calciﬁcation
of the AAA. Arterial calciﬁcation has had little attention as a
risk factor in AAA diagnostics. For the largest part this is
owing to a lack of validated calciﬁcation measurement tools
for clinical application. Though computational analysis of
calciﬁcation of the coronary vessels has been validated
rigorously, no such tool has been developed for larger
vessels such as the abdominal aorta. In this study, a visual
calciﬁcation grading tool, the Abdominal Aortic
Calciﬁcation-8 (AAC-8) score, will be employed for the
scoring of standard care abdominal computed tomography
angiography (CTA) images. The aim of this study was
to assess whether aneurysm calciﬁcation is correlated
to rupture in a retrospective unmatched case-control
population.
MATERIALS AND METHODS
Study design
All patients diagnosed with an AAA from the start of 2005
to 2011 were retrospectively collected from a central pa-
tient database at the Department of Surgery (Division of
Vascular Surgery) at our center. During this period, 911
patients were considered for treatment of AAA. Three
groups of patients were distinguished on the likelihood and
event of rupture. The elective group (eAAA) consisted of
patients who had received elective surgery following an
AAA diameter measurement of >5.0 cm or >5.5 cm for
women or men, respectively, or AAA growth of >5 mm
within 6 months (n ¼ 780). The symptomatic group (sAAA)
was comprised of patients who had been diagnosed with an
AAA on computed tomography (CT) (n ¼ 32). These patients
received CT imaging based on having lower back pain,
tenderness of the abdomen, or a pulsating abdominal mass
that was painful on palpation, without signs of rupture. The
ruptured AAA group (rAAA) contained patients who had
been diagnosed with having acute signs of rupture, such as
hypotension and retroperitoneal hemorrhage on either CTA
or during surgery (n ¼ 99). CTA scans of 28 sAAA and 73
rAAA patients were acquired. As a control group, 233 eAAA
patients were collected from the database. The following
common clinical and demographic variables were included
in our analysis: AAA diameter, gender, age, body mass index,
systolic, diastolic and mean arterial blood pressure, and
serum creatinine levels. For all patients, these variables
were collected and measured by independent clinicians in
the non-critical setting. Age- and gender-matching was
performed based on this information (Tables 1 and 2). After
matching, ﬁve sAAA and ﬁve rAAA patients could not be
matched to control patients and were excluded. Of theeAAA patients, three could not be matched to case patients
and were also excluded. For eAAA patients, this was the day
before intervention. For sAAA and rAAA patients, this data
was collected from the last non-critical measurement within
1 year before the intervention. These were performed
either at hospital admission or during routine check-ups by
general practitioners. In some cases, serum creatinine levels
of sAAA and rAAA patients could not be collected because
544 R.V.C. Buijs et al.these criteria were not met. The following comorbidities
were also screened for: diabetes mellitus type 1 or 2
(DM),12 chronic obstructive pulmonary disease (COPD),13
and known cardiovascular disease (CVD).1 CVD was
deﬁned as either one of the following illnesses. First of all,
coronary heart disease (CHD), either in the form of angina
pectoris, myocardial infarction, heart failure or death due to
CHD. Cerebrovascular disease, such as transient ischemic
attack and stroke, were also regarded as CVD. Though pe-
ripheral artery disease (PAD) and thoracic, femoral, iliac,
and popliteal aneurysms are also regarded as CVD, we
separately studied the distribution of these clinical entities.
Information on smoking history, family history of AAA, and
history of hypertension was also collected. A family physi-
cian or a specialist diagnosed DM, COPD, CVD, and hyper-
tension previous to this study. At >1 cigarette daily at least
1 year prior to the AAA repair, a patient was classiﬁed as a
smoker. To some extent, all of these factors are known to
affect cardiovascular risk and were therefore included to
correct for confounding.14e16 All AAAs in this study were
classiﬁed by their diameter by independent radiologists
prior to the study. Because sAAA can be particularly difﬁcult
to diagnose, each documented case was retrospectively
reassessed. Patients were regarded as sAAA in case the AAA
symptoms had receded after treatment or if the symptoms
could not be attributed to non-AAA pathology. The exact
diameter for each patient was measured and documented
in the hospital archives previous to this study as part of
routine care. Ethical approval for the study was gained from
the Institutional Review Board (METc2013-171). Informed
consent was not required for this project.Figure 1. A sagittal maximum intensity projection image from a
thoracic computed tomography scan in an abdominal aortic
aneurysm patient with abundant calciﬁed structures.AAA calciﬁcation measurements
Independent radiologists conﬁrmed the clinical diagnosis
“AAA” for both the eAAA and non-eAAA groups. For anal-
ysis of CT images the AquariusNet Viewer Client V4.4.4.23
(TeraRecon, Foster City, CA, USA) was used. To reliably im-
age all calciﬁcations in the three-dimensional (3D) plane, a
maximum intensity projection was created from a sagittal
perspective. The window level of each image was ﬁrst
adjusted in the AquariusNet Viewer Client. Iodine-contrast
signal intensity has lower Hounsﬁeld units (HU) than calci-
ﬁcation. Therefore, by increasing the window level so that
the iodine-contrast signal intensity becomes barely visible,
calciﬁcation remains highly visible and no calciﬁcation signal
is lost. Calciﬁcation in the AAA wall was later measured
semi-quantitatively using the AAC-8, as described in earlier
studies.17,18 This is a simpliﬁed version of the AAC-24 score
developed by Kauppila et al.19 The severity of calciﬁcation is
measured in points. These points are assigned to the
presence of very high-density signals on the anterior and
posterior walls of the abdominal aorta between the ﬁrst
and fourth lumbar vertebra. Therefore, one grade is given
for the presence of calciﬁcation in the abdominal aorta
alongside one vertebra on either the anterior or posterior
side. If the calciﬁcation has an aggregate length of more
than one vertebra, the grade increases one point and soforth. The cumulative points of both the anterior and pos-
terior wall represent the AAC-8 score (Figs. 1e3). Agree-
ment for inter-rater reliability of the AAC-8 score was good
(Kappa ¼ .69; p < .001).Statistical analysis
In addition to the separate statistical analysis of each group,
sAAA and rAAA patient groups were also combined and
labeled as non-eAAA. The distribution of calciﬁcation scores
in groups with low-risk (50 mm or 55 mm for women
and men patients, respectively) versus high-risk aneurysm
(>50 mm or >55 mm for women and men, respectively)
were also analyzed. Demographic statistics were expressed
as mean  SD; 95% conﬁdence interval (CI) for continuous
variables for eAAA versus non-eAAA, respectively. Percent-
ages were given for nominal variables, and medians and
interquartile ranges for skewed distributed variables. The
demographic variables of non-eAAA patients and eAAA
patients were compared. Cross-tabulation was used to
compare nominal variables. Continuous data were analyzed
using Student t test in case of normal distribution. Manne
Whitney U tests were performed for comparison of skewed
continuous variables. Multivariate analysis was performed
for the association between the patient groups (eAAA vs.
non-eAAA) as the dependent variable and explanatory
variables such as AAC-8 score and demographic variables.
Figure 2. A sagittal maximum intensity projection image from a
thoracic computed tomography scan in an abdominal aortic
aneurysm patient with few calciﬁed structures.
Figure 3. A sagittal maximum intensity projection image from a
thoracic computed tomography scan in an abdominal aortic
aneurysm (AAA) patient with visualization of the measurement
protocol according to the Abdominal Aortic Calciﬁcation-8 score.
Each lumbar vertebra up to number four has been numbered. A
crude midline is drawn to show the anterior and posterior side of
the AAA. The calciﬁcations alongside the most ventral and dorsal
wall are counted as either present or absent.
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provided the predictive value of several explanatory vari-
ables. Inter-rater reliability was measured using weighted
Kappa after cross-tabulation of measurements by the main
researcher (R. B.) and an experienced trained observer.
Signiﬁcance was set at p .05. All statistical analyses were
performed using SPSS 20 (IBM, Armonk, NY, USA), except
for the inter-rater reliability, for which STATA 11.2 (Stata-
Corp, College Station, TX, USA) was used.
RESULTS
Patient characteristics
Patients who had never smoked were more often found in
the non-eAAA group (p ¼ .013). All eAAA patients received
treatment, whereas 9% of non-eAAA patients did not
receive surgery, either because of pre-operative death,
refusal of, or contra-indication to, intervention. Treatment
of eAAA patients was signiﬁcantly more often by endovas-
cular repair (p < .001), whereas non-eAAA patients
received open repair more frequently (p ¼ .003) (Table 1).
Patients with PAD were signiﬁcantly overrepresented in the
eAAA group (21%) as opposed to only 8% in the non-eAAA
group (p ¼ .004). Age, serum creatinine, body mass index,
current smoking habit, a history of cardiovascular disease,
having stopped smoking, systolic blood pressure, diastolic
blood pressure, and mean arterial pressure either varied
slightly, insigniﬁcantly, or both between the groups eAAA
and non-eAAA (Table 1). The frequency of COPD,hypertension, and familial AAA incidence were also
distributed equally over both groups.
AAA diameter versus calciﬁcation
Aneurysm size differed strongly between eAAA and non-
eAAA patients (62  12 mm vs. 77  20 mm; p < .001).
Patients with eAAAs had a mean AAC-8 score of 3.4  2
points, whilst rAAA patients had a score of 4.9  2.2 points
(p < .001). Between sAAA and rAAA patients, the difference
was smaller and no longer signiﬁcant (5.1  2.3 points vs.
4.8  2.2 points; p ¼ .55).
For the eAAA, sAAA and rAAA groups the AAA diameter
measurements and AAC-8 score were plotted in an error
bar (Fig. 4). The mean AAA diameter was highest in the
rAAA group (79 mm; 95% CI: 74e83, followed by the sAAA
group [72 mm; 95% CI: 63e82]). The AAA diameter was
lowest in eAAA patients. The AAC-8 scores were highest for
sAAA patients. Patients with rAAA had the next highest
AAC-8 scores. Patients with eAAA had the lowest mean
AAC-8 score (Fig. 5). The combined predictive value of
calciﬁcation and diameter are seen in Table 2. The distri-
bution of patients with high-risk diameters and high calci-
ﬁcation scores was signiﬁcantly more pronounced in non-
Figure 4. 95% Conﬁdence interval (CI) of the mean bar graph of
abdominal aortic aneurysm (AAA) diameter size for elective,
ruptured, and symptomatic AAAs. Note. *p < .05.
546 R.V.C. Buijs et al.eAAA (55%) than eAAA patients (29%; p < .001). Patients
who only had high calciﬁcation scores and small diameters
comprised only 3% of the eAAA group versus 6% in the non-
eAAA group, though this difference was not signiﬁcant
(p ¼ .2). Large diameters with low calciﬁcation scores were
seen signiﬁcantly more frequent in eAAA patients (63%)Figure 5. 95% Conﬁdence interval (CI) of the mean bar graph of the
Abdominal Aortic Calciﬁcation-8 (AAC-8) score for elective,
ruptured, and symptomatic abdominal aortic aneurysms (AAAs).
Note. *p < .05.than in non-eAAA patients (40%; p < .001). Finally, there
were no differences in the degree of calciﬁcation when
patients were segregated into two groups according to
aortic diameter (Fig. 6).
Regression analysis
Correlation coefﬁcients were ﬁrst calculated in the eAAA
and non-eAAA patient groups. Variables that maintained
signiﬁcance after logistic regression were AAA diameter,
AAC-8 score, non-smoking, and history of PAD (Table 3).
Patients with concomitant PAD were more often placed in
the non-eAAA group with an odds ratio (OR) of 0.39 (95%
CI: 0.15e1.00; p ¼ .049). The AAA diameter had an OR of
1.062 (95% CI: 1.042e1.082; p < .001) for each mm in-
crease compared with an OR of 1.35 (95% CI: 0.15e1.00;
p < .001) for each point increase of the AAC-8 score.
DISCUSSION
In this study we assessed the correlation of calciﬁcation
with aneurysm rupture risk. The amount of calciﬁcation in
the abdominal aortic wall was higher in ruptured and
symptomatic patients than in electively operated AAA pa-
tients. However, possible confounding factors appeared to
be unequally distributed over the different groups. Patients
with a history of PAD were found mostly in the eAAA group.
Also, a fair number of patients did not undergo, or chose
not to receive, surgery in the rAAA group, while all sAAA
and eAAA patients did receive surgery. This phenomenon is
understandable given the fact that the rAAA patient group
has the largest pre-operative mortality rate. Other potential
confounders were either evenly distributed over the patientFigure 6. Box plot of Abdominal Aortic Calciﬁcation-8 (AAC-8)
score distribution in a low-risk diameter and a high-risk diameter
group. High-risk diameter: >50 mm for women and >55 mm for
men.
Table 3. Odds ratios (OR) for risk factors for rupture in elective
abdominal aortic aneurysms (AAA) versus non-elective AAA.
Variable p OR 95% CI
AAC-8 (points) <.001 1.35 1.19e1.53
AAA diameter (mm) <.001 1.062 1.042e1.082
Smoking (never) (%) .15 1.54 0.86e2.76
Peripheral artery disease (%) .049 0.39 0.15e1.00
Note. AAC-8 ¼ Abdominal Aortic Calciﬁcation-8 score;
CI ¼ conﬁdence interval.
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calciﬁcation scores in small versus high-risk diameter groups
also showed that calciﬁcation scores were similar in both
groups. Therefore, there does not seem to be major
dependence of calciﬁcation score on aneurysm diameter.
Nevertheless, when comparing the added predictive value
of either calciﬁcation to diameter or vice versa, it is clear
that a combination of >50% calciﬁcation and high-risk
diameter size is more pronounced in the non-eAAA group.
In comparison with the AAA diameter, the AAC-8 score was
higher in sAAA than in eAAA patients. Most importantly,
higher rates of both calciﬁcation and AAA diameter were
found in the non-eAAA group than in the eAAA group. We
therefore state that calciﬁcation has value not only as an
addendum to diameter, but could also be associated with
the development of symptoms in AAA patients. From the
multivariate analysis between eAAA and non-eAAA pa-
tients, we can derive that an increase of either the AAC-8
score or AAA diameter is predictive of rupture and/or
development of symptoms.
To our knowledge, no previous studies have investigated
the value of calciﬁcation in elective versus non-elective AAA
patients. Some researchers, however, have provided basic
research and computational data that support our ﬁndings.
Li et al.10 performed a computational study in which CTA
images of 20 patients were reconstructed as a digital 3D
model. The authors concluded that a causal relationship
exists between calciﬁcation and signiﬁcantly higher local
wall stress. This, in turn, can decrease the AAA wall stability
and, consequently, increase the risk of rupture. New et al.11
described biochemical analyses of calciﬁed AAA and stated
that micro-calciﬁcations of the AAA entail inﬂammatory
cytokines, while macrocalciﬁcation plaques are more stable.
Calciﬁcation would subsequently deteriorate the structural
integrity of the wall. Both Li et al.10 and New et al.11 pro-
vided a pathophysiological basis for our ﬁndings. Recently,
Dweck et al.20 were able to perform a functional analysis of
the coronary arteries with 18F-sodium ﬂuoride positron
emission tomographyeCT. In their study, they perceived a
clear rise in cardiovascular risk in correlation with the ac-
tivity of micro-calciﬁcations. Though CTA is not capable of
discriminating between active and inactive calciﬁcation, it
may provide a clinically applicable tool in distinguishing
micro- from macro-calciﬁcations. The AAC-8 score is not
suited to reliably differentiate between these two forms of
calciﬁcation. The development of a quantitative calciﬁcation
measurement tool could provide a widely applicable
method to estimate the pathophysiological processesdescribed above. Therefore, we plan to further study the
inﬂuence of calciﬁcation on these processes and vice versa.
A study by Lindholt22 showed conﬂicting results. In this
study, survival curves for mortality and cardiovascular
events showed no signiﬁcant differences in AAA with >50%
versus <50% circumferential vessel calciﬁcation. However, a
lower rate of expansion and decreased admission for sur-
gery was observed for the group with >50% calciﬁcation.
These potentially protective effects might oppose the pre-
vious ﬁndings, as well as the results presented here. The
potential differences of the inﬂuence of macro- and micro-
calciﬁcations were not addressed in this study. Besides, the
author stated that the reproducibility of the observations is
uncertain. The AAC-8 score applied in our study does not
account for circumferential calciﬁcation. It allows for mea-
surement in the sagittal plane and might therefore not be
directly extrapolated to the results found by Lindholt.21
This study utilises the AAC-8 score, a method that has
been used and validated in X-ray studies.15,22 Before the
AAC-8 score was introduced, Agatston et al.23 had already
constructed a computational method that could translate
signal intensity as a function of HU into a quantiﬁable de-
gree of calciﬁcation in coronary arteries. Callister et al.24
validated a similar method, also based on HU, to calculate
the total calciﬁed volume. The strength of the AAC-8 score
over the Agatston or Callister methods is its practicality in
the clinical setting. Both the Agatston and Callister methods
can only interpret calciﬁcation in non-contrast CT images.
However, in the Netherlands the pre-operative anatomical
assessment of the AAA is performed solely with CT angi-
ography. Therefore, the Agatston and Callister methods
currently have no clinical value as opposed to the AAC-8
score. If a more accurate method of calciﬁcation measure-
ment was to be applied in routine clinical practice, this
could be used to validate the role of calciﬁcation in large
groups of patients. Development of software tools appli-
cable to CT angiograms will prove to be critical in enabling
such widespread use of calciﬁcation scores.
There are several limitations of this study. First, it should
be underscored that the data for this study were collected
retrospectively. Selection bias and confounding by known
and unknown factors are the bane of retrospective studies.
We have attempted to minimize selection bias in our pop-
ulation by including all patients for whom CT images were
available. Patients treated before 2005 were less likely to
have available CT images than patients from 2005 onwards.
We have included and assessed many of the possible con-
founders that have been identiﬁed in the current medical
literature to minimize confounding. Naturally, other limita-
tions apply to prospective research, though follow-up
studies in a prospective manner would certainly be
needed to substantiate our results.
The AAC-8 score remains highly observer-dependent.
A fully computational, observer-independent method will
provide better reproducibility and validity. There is currently
no such method for contrast-enhanced and unenhanced CT
images. Still, inter-rater reliability in this study was good,
conﬁrming, at least, that the AAC-8 score is a fairly
548 R.V.C. Buijs et al.reproducible method. Though this study has promising re-
sults considering the relation between calciﬁcation and
rupture, still very little can be said about causality. Further
basic research on the interactions between calciﬁcation and
aneurysm-forming is needed to place the results of this
study in perspective.
We found a trend of increased abdominal aortic calciﬁ-
cation in patients with ruptured and symptomatic AAA as
opposed to those undergoing elective repair. The maximum
aortic diameter correlated well with symptomatology and
rupture as expected. The AAC-8 score, but not AAA diam-
eter, appeared to discriminate the group with symptomatic
aneurysms from those undergoing elective repair. The re-
sults of this study suggest that calciﬁcation of the abdom-
inal aorta might have predictive value. Additional research
regarding the effects of calciﬁcation on vessel structure is
needed to clarify the relation between calciﬁcation and
rupture. Finally, this study shows a clear association of
increased aortic calciﬁcation with aneurysm rupture.
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